ACM Research enters the back end of August caught between two opposing signals: a fresh analyst initiation with a bullish $136 target and a CFO who just sold over $4.2 million of stock near current prices.
The insider angle is the week's sharpest tension. CFO Mark McKechnie sold 55,199 shares across three tranches on August 20, raising $4.26 million at prices between $76.34 and $77.89 — just below where the stock trades now at $79.77. An independent director, Haiping Dun, added further selling two days earlier, offloading roughly 5,000 shares around $81. Net insider activity over the past 90 days is technically positive at roughly $15 million, but that figure reflects equity compensation mechanics rather than open-market buying — the recent activity is one-directional selling by two distinct insiders within the same week, which is worth noting regardless of the dollar sign.
The lending market offers no particular drama here. Short interest runs at 6.1% of the free float — meaningful but not extreme — and has edged up roughly 10% over the past month, reversing some of the decline seen through July. Borrow costs have actually eased, dropping 17% on the week to just 0.38%, a low level by any measure. Availability remains exceptionally loose at over 1,500% — meaning shares to borrow vastly outnumber existing shorts — so there is no squeeze dynamic in play. Options positioning is similarly calm: the put/call ratio of 0.42 sits almost exactly in line with its 20-day average, with a z-score barely above zero. Nothing in the positioning data suggests either aggressive short conviction or unusual hedging demand.
The Street, by contrast, is turning more constructive. Daiwa Capital initiated coverage this week with a Buy and a $136 target, landing well above the current price and above the consensus mean of $117.75. Morgan Stanley raised its target to $130 in late June while maintaining Overweight, and Roth Capital lifted to $125 around the same time. The analyst community — six Buy ratings against zero visible sells — is aligned around the bull case: a $1.27 billion backlog up 34% annually, and China semiconductor capacity expansion sustaining demand for ACM's cleaning and surface-prep equipment. Bears counter that the business is exposed to equipment spending cycles and concentrated in a single geography where macro risk and geopolitical scrutiny remain elevated. The PE has compressed about 9 points over the past 30 days to roughly 33x, and EV/EBITDA has pulled back by a similar magnitude — the stock has re-rated lower even as the analyst community has held firm.
The peer group context adds colour. MKSI fell nearly 10% on the week and ICHR dropped over 13%. COHU shed more than 14%. ACMR's 5.5% weekly decline looks modest by comparison, suggesting relative resilience in a tough tape for the capital equipment cohort — though the stock is still down about 5% over the past month, broadly in line with the group. The most recent earnings print, reported August 7, produced a negligible one-day move of 0.5%, followed by a 1.8% gain over five days. The prior quarter saw a 4.3% one-day drop. With the next event not until November 5, the near-term narrative is largely analyst-driven rather than event-driven.
The next few weeks will test whether the fresh Daiwa initiation attracts new institutional interest or whether continued insider selling — and a sector-wide valuation reset — keeps the stock range-bound below the $85–90 level it has struggled to clear in recent months.
See the live data behind this article on ORTEX.
Open ACMR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
